APO-SALVENT AEM 100MCG

Main information

  • Trade name:
  • APO-SALVENT AEM 100MCG METERED-DOSE AEROSOL
  • Dosage:
  • 100MCG
  • Pharmaceutical form:
  • METERED-DOSE AEROSOL
  • Composition:
  • SALBUTAMOL 100MCG
  • Administration route:
  • INHALATION
  • Units in package:
  • 200
  • Prescription type:
  • Prescription
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • APO-SALVENT AEM 100MCG METERED-DOSE AEROSOL
    Canada
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • SELECTIVE BETA 2-ADRENERGIC AGONISTS
  • Product summary:
  • Active ingredient group (AIG) number: 0108887003; AHFS: 12:12.08.12

Other information

Status

  • Source:
  • Health Canada
  • Authorization status:
  • MARKETED
  • Authorization number:
  • 00790419
  • Authorization date:
  • 31-12-1989
  • Last update:
  • 27-11-2018

10-11-2018

Pest categorisation of Popillia japonica

Pest categorisation of Popillia japonica

Published on: Thu, 08 Nov 2018 00:00:00 +0100 The Panel on Plant Health performed a pest categorisation of Popillia japonica(Coleoptera: Scarabaeidae) for the EU. P. japonica is a distinguishable species listed in Annex IAII of Council Directive 2000/29/EC. It is native to Japan but established in the USA in the early 20th century. It spreads from New Jersey to most US states east of the Mississippi, some to the west and north into Canada. P. japonica feeds on over 700 plant species. Adults attack folia...

Europe - EFSA - European Food Safety Authority Publications

11-9-2018

Risk assessment of substances used in food supplements: the example of the botanical Gymnema sylvestre

Risk assessment of substances used in food supplements: the example of the botanical Gymnema sylvestre

Published on: Tue, 28 Aug 2018 00:00:00 +0200 Botanicals and preparations derived from these are among the substances frequently added to foods and food supplements, yet the safety of many botanicals has not been systematically assessed. In the context of the EU‐FORA fellowship programme, the fellow performed an assessment on the safety of the botanical Gymnema sylvestre, in accordance with EFSA's guidance on the assessment of safety of botanicals. Although preparations of G. sylvestre are marketed as f...

Europe - EFSA - European Food Safety Authority Publications

18-7-2018

Orphan designation:  Azacitidine,  for the: Treatment of acute myeloid leukaemia

Orphan designation: Azacitidine, for the: Treatment of acute myeloid leukaemia

Europe - EMA - European Medicines Agency

13-6-2018

Orphan designation:  Ivosidenib,  for the: Treatment of acute myeloid leukaemia

Orphan designation: Ivosidenib, for the: Treatment of acute myeloid leukaemia

Europe - EMA - European Medicines Agency

9-6-2018

Caito Foods, LLC Voluntarily Recalls Fresh Cut Melon Products Because of Possible Health Risk

Caito Foods, LLC Voluntarily Recalls Fresh Cut Melon Products Because of Possible Health Risk

Caito Foods is voluntarily recalling fresh cut watermelon, honeydew melon, cantaloupe and fresh-cut mixed fruit containing one of these melons, produced at the Caito Foods facility in Indianapolis, because these products have the potential to be contaminated with Salmonella.

FDA - U.S. Food and Drug Administration

29-5-2018

Orphan designation:  Nilotinib,  for the: Treatment of chronic myeloid leukaemia

Orphan designation: Nilotinib, for the: Treatment of chronic myeloid leukaemia

Europe - EMA - European Medicines Agency

29-5-2018

Orphan designation:  Midostaurin,  for the: Treatment of acute myeloid leukaemia

Orphan designation: Midostaurin, for the: Treatment of acute myeloid leukaemia

Europe - EMA - European Medicines Agency

29-5-2018

Orphan designation:  Venetoclax,  for the: Treatment of acute myeloid leukaemia

Orphan designation: Venetoclax, for the: Treatment of acute myeloid leukaemia

Europe - EMA - European Medicines Agency

7-5-2018

Orphan designation:  Bosutinib,  for the: Treatment of chronic myeloid leukaemia

Orphan designation: Bosutinib, for the: Treatment of chronic myeloid leukaemia

Europe - EMA - European Medicines Agency

23-10-2013

Danish Pharmacovigilance Update, 29 August 2013

Danish Pharmacovigilance Update, 29 August 2013

In this issue of Danish Pharmacovigilance Update: Cases of acquired haemophilia following treatment with clopidogrel (Plavix® etc.)

Danish Medicines Agency

29-5-2013

Danish Pharmacovigilance Update, 25 April 2013

Danish Pharmacovigilance Update, 25 April 2013

In this issue of Danish Pharmacovigilance Update: Cerebral haemorrhage in association with the use of methylphenidate (Ritalin® etc.).

Danish Medicines Agency

26-1-2012

Danish Pharmacovigilance Update, 19 January 2012

Danish Pharmacovigilance Update, 19 January 2012

In this issue of Danish Pharmacovigilance Update read about the risk that patients treated with statins develop diabetes, and proton-pump inhibitors (PPI) and the risk of hypomagnesaemia with long-term use.

Danish Medicines Agency

18-3-2008

Warning about Power 1 Walnut

Warning about Power 1 Walnut

The Danish Medicines Agency has been made aware that the Health Sciences Authority in Singapore has confiscated large quantities of the illegal medicinal product Power 1 Walnut, which has been marketed as a potency-enhancing product containing only herbs.

Danish Medicines Agency

25-10-2018

Canigen L4 (Intervet International B.V.)

Canigen L4 (Intervet International B.V.)

Canigen L4 (Active substance: Leptospira interrogans serogroup Canicola serovar Portland-vere/Leptospira interrogans serogroup Icterohaemorrhagiae serovar Copenhageni/Leptospira interrogans serogroup Australis serovar Bratislava/Leptospira kirschneri serogroup Grippotyphosa serovar Dadas) - Centralised - Yearly update - Commission Decision (2018)7138 of Thu, 25 Oct 2018

Europe -DG Health and Food Safety

10-9-2018

Silapo (STADA Arzneimittel AG)

Silapo (STADA Arzneimittel AG)

Silapo (Active substance: epoetin zeta) - Centralised - Yearly update - Commission Decision (2018)5944 of Mon, 10 Sep 2018

Europe -DG Health and Food Safety

22-8-2018

Leucogen (Virbac)

Leucogen (Virbac)

Leucogen (Active substance: Feline leukaemia vaccine (inactivated)) - Centralised - 2-Monthly update - Commission Decision (2018)5625 of Wed, 22 Aug 2018 European Medicines Agency (EMA) procedure number: EMEA/V/C/144/WS1282/6

Europe -DG Health and Food Safety

14-8-2018

Nobivac LeuFel (Virbac)

Nobivac LeuFel (Virbac)

Nobivac LeuFel (Active substance: Feline leukaemia vaccine (inactivated)) - Centralised - 2-Monthly update - Commission Decision (2018)5535 of Tue, 14 Aug 2018 European Medicines Agency (EMA) procedure number: EMEA/V/C/4778/WS/1282/1

Europe -DG Health and Food Safety

3-5-2018

Agenda:  Agenda – Haemophilia registries workshop

Agenda: Agenda – Haemophilia registries workshop

Europe - EMA - European Medicines Agency

18-4-2018

Melatonin (haemorrhage) (Therapicon Srl)

Melatonin (haemorrhage) (Therapicon Srl)

Melatonin (haemorrhage) (Active substance: Melatonin) - Refusal of orphan designation - Commission Decision (2018)2410 of Wed, 18 Apr 2018 European Medicines Agency (EMA) procedure number: EMA/OD/127/17

Europe -DG Health and Food Safety